Appendectomy
Introduction
Appendectomy is the surgical procedure for the removal of the appendix, primarily performed to treat acute appendicitis, a common and potentially serious inflammation of the vermiform appendix. This condition affects approximately 9% of Americans and is a leading cause for emergency abdominal surgery and hospitalization in both children and adults. [1] Acute appendicitis is more prevalent in males than females, with a ratio of about 1.4:1, and most frequently occurs in individuals during their second and third decades of life. [1] Without timely surgical intervention, appendicitis can lead to severe complications such as appendiceal perforation, peritonitis, and sepsis, which significantly increase morbidity and mortality. Roughly 30% of patients present with advanced disease, necessitating prolonged hospitalization and resulting in higher complication rates. [1]
Biological Basis
The vermiform appendix, a small, finger-shaped pouch projecting from the large intestine, is often considered vestigial. However, some research suggests it may play a role in maintaining a healthy gut microbiota. [1] Acute appendicitis, its inflammation, is a complex condition whose exact pathophysiology is not fully understood, and it appears to be distinct from other inflammatory disorders of the gastrointestinal tract. [1] While historical theories often attributed appendicitis to obstruction by fecaliths or lymphoid hyperplasia, these have not been consistently verified experimentally. [1]
Genetic factors are recognized as contributing to an individual's susceptibility to appendicitis, with heritability estimates ranging between 27% and 56% derived from various family and twin studies. [1] Recent genome-wide association studies (GWAS) have identified specific genetic loci associated with appendicitis. Notably, a significant association has been observed on chromosome 4q25 near the PITX2 gene, with the lead SNP rs2129979. [1] This variant has shown strong cumulative evidence of association across multiple cohorts, with an odds ratio of 1.12 (95% CI 1.09–1.14; p-value = 1.81 × 10[1] ). [1] The PITX2 gene encodes Paired-Like Homeodomain 2, a transcription factor crucial for tissue-specific cell proliferation, left-right asymmetry during fetal development, and the morphogenesis of the cecum, the anatomical site where the appendix develops. [1] Non-coding variants in this region, such as rs2129979, are thought to exert their influence by regulating gene expression. Studies have demonstrated that PITX2 exhibits significant differential expression across varying categories of appendix inflammation, from uninflamed to perforated tissue. [1] It has been noted that the association with PITX2 was stronger in adults than in children, suggesting potentially different genetic mechanisms or effect sizes across age groups. [1]
Clinical and Social Importance
Appendectomy remains the primary and most effective treatment for acute appendicitis, preventing life-threatening complications. The ability to accurately identify individuals at higher genetic risk could, in the future, inform diagnostic approaches or even preventative strategies, although current practice relies on clinical presentation and diagnostic imaging. The widespread occurrence of appendicitis and the necessity of surgical intervention place a substantial burden on healthcare systems globally, highlighting the clinical and social importance of understanding its etiology. Further genetic research into appendicitis and appendectomy aims to uncover additional risk factors and pathways, potentially leading to improved patient outcomes and more targeted medical interventions.
Phenotype Definition and Generalizability
A significant limitation stems from the reliance on self-reported appendectomy for phenotype ascertainment in both the discovery and replication cohorts. While this method proved viable in identifying a strong association, it introduces the potential for misclassification due to the occurrence of incidental appendectomies—surgeries not performed for acute appendicitis—and the inherent fallibility of personal recall of medical procedures. Such misclassification would primarily bias the genome-wide association study (GWAS) results towards the null hypothesis, meaning that true genetic associations could have been overlooked, even though observed associations are unlikely to be false positives stemming from this data collection method. [2]
The generalizability of these findings is further constrained by the study's design, which focused exclusively on participants of at least 97% European ancestry. This demographic restriction means the identified genetic associations may not be directly applicable to individuals of other ancestral backgrounds, limiting the broader understanding of appendicitis susceptibility across diverse global populations. [2] Furthermore, the gene expression analysis was conducted on appendix samples solely from a pediatric population (ages 5–18 years), and previous research has indicated that the association of the lead SNP near PITX2 with appendicitis may strengthen with increasing age of onset. [3] This age-specific sampling, coupled with a lack of age-at-appendectomy data in the discovery cohort and insufficient power in the replication cohort for age-of-onset stratification, restricts the interpretation of expression results to pediatric-onset disease and prevents generalization to adult-onset appendicitis. [2]
Statistical Power and Replication Challenges
The study encountered limitations related to statistical power and the comprehensive replication of all identified genetic signals. Specifically, the COHRA1 replication cohort was underpowered to consistently detect all signals observed in the larger discovery dataset, which could lead to an underestimation of the full genetic landscape of appendicitis susceptibility. [2] Additionally, two of the nine loci that showed genome-wide or suggestive significance in the discovery GWAS could not be tested for replication due to low minor allele frequency or the unavailability of suitable surrogate single nucleotide polymorphisms (SNPs) in high linkage disequilibrium, leaving their association unconfirmed. [2]
Furthermore, while the lead discovery SNP, rs2129979, demonstrated strong cumulative evidence of association across multiple cohorts in a meta-analysis, a statistically significant genetic heterogeneity was observed. [2] This heterogeneity, indicated by Cochran’s Q statistic, suggests that the genetic effects of this locus may vary across different cohorts. This variability complicates a uniform interpretation of its impact on appendicitis risk and highlights potential underlying differences in genetic architecture or environmental interactions not fully captured. [2]
Mechanistic Understanding and Remaining Knowledge Gaps
A key limitation lies in the current understanding of the functional mechanisms through which the identified genetic variants contribute to appendicitis susceptibility. The most significantly associated SNPs, including those near PITX2, are non-coding, meaning their statistical association does not directly elucidate the biological pathways or specific molecular changes they induce to impact disease risk. [2] While the study investigated gene expression, the selection of genes for the expression panel was partly guided by RegulomeDB for eQTL targets; however, the inaccessibility of alternative, potentially richer, eQTL datasets like GTEx during the study design phase may have limited the scope of genes investigated and potentially overlooked other crucial insights into regulatory functions. [2]
Despite evidence suggesting a substantial heritable component to appendicitis, ranging from 27% to 56%, the identified genetic variants account for only a fraction of this heritability, indicating significant remaining knowledge gaps. [2] Many other genetic factors contributing to appendicitis susceptibility are yet to be discovered, and the broader pathophysiological mechanisms of the disease itself remain without a definitive consensus. [2] This absence of a complete mechanistic understanding makes it challenging to fully interpret the roles of the discovered genetic associations within the complex etiology of appendicitis. [2]
Variants
The genetic predisposition to conditions like appendicitis, often inferred through appendectomy, involves a complex interplay of various genetic factors, including non-coding RNA variants that influence gene regulation and immune responses. [1] Long intergenic non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are crucial regulators of gene expression, with roles spanning development, cellular differentiation, and immune system modulation. [1] Variations within these non-coding regions, even if not directly altering protein sequences, can profoundly impact disease susceptibility by altering the expression or function of these regulatory molecules.
The variant rs13121924 is associated with LINC01438 and MIR297, both of which are non-coding RNAs with significant regulatory potential. LINC01438 is a long intergenic non-coding RNA, a class of RNA molecules known to regulate gene expression through diverse mechanisms, including chromatin remodeling, transcriptional interference, and post-transcriptional processing. [1] Its activity can influence cellular pathways relevant to inflammation and tissue homeostasis, which are central to the pathogenesis of appendicitis. Concurrently, MIR297 is a microRNA, a small RNA that typically represses gene expression by binding to target messenger RNAs, thereby affecting protein production. [1] A variant like rs13121924 could impact the expression levels or processing of LINC01438 or MIR297, potentially leading to altered inflammatory responses or compromised tissue repair in the appendix, thereby influencing the risk of appendicitis requiring appendectomy.
Similarly, rs11413982 is linked to LINC02945, and rs114998640 is associated with LINC00607, both of which are long intergenic non-coding RNAs. These lncRNAs are integral to various biological processes, including the regulation of immune cell function and maintaining the integrity of epithelial barriers, such as those found in the gastrointestinal tract. [1] The appendix, being a lymphoid organ within the gut, relies on a robust immune response and an intact epithelial lining to prevent inflammation. Variants like rs11413982 and rs114998640 could modify the expression or stability of LINC02945 and LINC00607, respectively. Such alterations might disrupt the delicate balance of immune regulation or compromise the intestinal barrier, increasing susceptibility to the acute inflammation characteristic of appendicitis. [1] These genetic variations highlight the importance of non-coding regions in modulating the risk for complex inflammatory conditions like appendicitis.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs13121924 | LINC01438 - MIR297 | appendectomy |
| rs11413982 | LINC02945 | appendectomy |
| rs114998640 | LINC00607 | appendectomy |
Surgical Management and Clinical Protocols
Acute appendicitis is a significant cause of morbidity globally, frequently necessitating emergent surgical intervention. [1] The primary and most common treatment protocol for appendicitis is appendectomy, the surgical removal of the inflamed appendix. [1] This procedure is widely performed across all age groups, addressing a condition that affects a substantial portion of the population. [4]
For pediatric patients with uncomplicated acute appendicitis, clinical protocols may include the consideration of nonoperative management as an alternative to immediate surgery. [5] While surgical intervention remains the standard, the option for patient choice in management highlights an evolving approach, particularly in less severe cases. However, timely diagnosis and intervention are crucial, as approximately 30% of affected individuals present with advanced disease, such as appendiceal perforation, which leads to longer hospitalizations and higher rates of complications. [6]
Pharmacological Support and Inflammatory Monitoring
Pharmacological support in the context of appendicitis primarily focuses on managing associated symptoms and post-operative complications. For instance, evidence-based analyses identify risk factors for postoperative nausea and vomiting (PONV), guiding prophylactic or therapeutic interventions to improve patient recovery after appendectomy. [7] While the provided research does not detail specific medications for treating appendicitis itself, understanding inflammatory responses is key to clinical assessment.
Studies have identified various serum and peritoneal inflammatory mediators, such as cytokines (e.g., interleukin-8), in individuals with suspected acute appendicitis, with levels potentially indicating the extent of the disease, including perforation. [8] Monitoring these markers can aid in diagnosis and assessing disease severity, although specific pharmacological treatments targeting these inflammatory pathways directly for appendicitis are not described in the provided context.
Dietary and Microbiome Approaches for Prevention
Preventive strategies for appendicitis include dietary and behavioral interventions, particularly focusing on the role of fiber intake and gut microbiota health. Research suggests a correlation between dietary fiber consumption and the incidence of appendicitis, with higher fiber intake potentially reducing risk. [9] This aligns with the understanding that a diet rich in fiber contributes to overall gut health.
The appendix itself is hypothesized to play a role in maintaining a healthy gut microbiota. [10] A diet lacking in fiber can lead to a gut microbiota that degrades the colonic mucus barrier, thereby increasing susceptibility to pathogens. [11] Therefore, promoting a balanced diet with adequate fiber may support a healthy gut microbiome, potentially reducing the risk of inflammation that can lead to appendicitis. [12]
Genetic Risk Factors and Early Identification
Understanding the genetic predisposition to appendicitis is crucial for risk assessment and potential early identification. Studies indicate a significant genetic component to appendicitis susceptibility, with heritability estimates ranging between 27% and 56%. [13] A genome-wide association study identified a significant locus at 4q25, with rs2129979 being a lead SNP, near the PITX2 gene, which encodes the transcription factor Paired-Like Homeodomain 2, as a risk factor for appendicitis. [1] PITX2 is known to be important in the morphogenesis of the cecum, where the appendix develops. [1]
While direct genetic interventions are not described, recognizing familial tendencies and genetic associations can inform clinicians about individuals who may have an elevated risk, emphasizing the importance of prompt evaluation for symptoms. [14] Early intervention upon symptom onset is critical to prevent progression to complicated appendicitis, such as perforation, which is associated with increased morbidity. [6] However, the genetic mechanisms may differ between children and adults, suggesting a need for age-specific risk factor assessment. [1]
Pathophysiology and Organ-Level Biology
Acute appendicitis, the inflammation of the vermiform appendix, is a common cause for emergent abdominal surgery, affecting approximately 9% of Americans. [4] While often considered a vestigial organ, the appendix may play a role in maintaining a healthy gut microbiota. [10] The disease process is characterized by inflammation, which can progress to perforation in about 30% of affected patients, leading to prolonged hospitalization and higher rates of complications. [6] Historically, obstruction by fecaliths or lymphoid hyperplasia was thought to be the primary cause, though experimental verification has been largely unsuccessful, and pathological reviews often do not confirm obstruction. [15] The pathophysiology of appendicitis is complex and appears distinct from other inflammatory disorders of the gastrointestinal tract. [16]
At the tissue and organ level, the inflammatory response in appendicitis involves the release of various mediators. Studies have shown the presence of peritoneal interleukin-8 in acute appendicitis [17] and elevated serum and peritoneal inflammatory mediators in children with suspected acute appendicitis. [8] Furthermore, human cytokine levels differ significantly between nonperforated and perforated cases, suggesting molecular markers could indicate the extent of the disease. [18] The condition is more prevalent in males than females, with a ratio of 1.4:1, and typically manifests in the second to third decades of life. [4]
Genetic Contributions to Appendicitis
Genetic factors play a significant role in an individual's susceptibility to appendicitis, with heritability estimates ranging between 27% and 56%. [13] Both genetic and environmental influences contribute to the risk, as evidenced by studies in twins. [14] A genome-wide association study (GWAS) identified a significant locus on chromosome 4q25, near the PITX2 gene, associated with appendectomy. [1] This association was consistently replicated across multiple cohorts, highlighting PITX2 as a key genetic risk factor. [1]
PITX2 encodes the Paired-Like Homeodomain 2 transcription factor, which is crucial for tissue-specific cell proliferation and establishing left-right asymmetry during fetal development. [1] Notably, PITX2 is important for the morphogenesis of the cecum, the region of the gut where the appendix develops. [1] The genetic variants associated with appendicitis are not protein-coding, suggesting they exert their influence through regulatory functions, potentially by altering PITX2 gene expression. [1] Even small changes in PITX2 expression, such as a 2.2-fold change, can lead to developmental defects in model organisms. [19]
Molecular and Cellular Mechanisms of Inflammation
Acute appendicitis is characterized by a specific and highly selective pattern of inflammatory gene expression within the affected tissue. [16] Research indicates differential expression of several genes across various stages of appendix inflammation, including uninflamed, mildly inflamed, severely inflamed, and perforated tissues. [1] Among these, PITX2, UBA7, CD53, and RHOA show significant expression trends. [1] PITX2 itself influences intestinal tissue morphology, contributes to an anti-oxidant response, and its expression levels correlate with intestinal bacteria and colonic inflammation. [1]
Another nominated gene candidate, RHOA (Ras Homolog Family Member A), demonstrates increasing expression with escalating appendix inflammation. [1] RHOA is a critical biomolecule involved in signal transduction and the dynamics of the actin cytoskeleton, essential for maintaining cellular structure and function. [1] Its functions are vital for intestinal epithelial cell integrity and it plays a role in controlling intestinal stem cell regeneration following injury or inflammation. [1] Furthermore, the microRNA miR-31 is often abnormally expressed in various inflammatory diseases, suggesting its potential involvement in the inflammatory processes observed in appendicitis. [20]
The Role of Gut Microbiota and Environmental Factors
Environmental factors, particularly diet, interact with genetic predispositions and the intestinal microbiome to influence the risk of appendicitis. [1] A diet low in fiber can significantly alter the composition of the intestinal microbiome and impact gut health. [21] Such a dietary deficiency can lead to the degradation of the colonic mucus barrier, thereby increasing the susceptibility of the intestinal epithelium to pathogens and triggering inflammation. [11]
The microbiota specifically within the appendix is known to be influenced by both dietary intake and an individual's genetics. [1] Studies have indicated that acute appendicitis in children is associated with an abundance of certain bacteria . Moreover, early life dietary exposures, such as maternal consumption of a Western-style diet, can induce differences in the intestinal microbiota, potentially impacting offspring susceptibility. [22] Therefore, the interplay between dietary habits, the gut microbial ecosystem, and host genetics forms a complex regulatory network that modulates inflammatory responses in the appendix.
Genetic Susceptibility and Risk Assessment
Appendicitis, a common condition requiring hospitalization for both children and adults, exhibits a significant genetic component, with heritability estimates ranging from 27% to 56%. [13] A genome-wide association study (GWAS) of appendectomy involving over 133,000 individuals identified a significant locus on chromosome 4q25 near the PITX2 gene, with the lead SNP rs2129979 showing robust association across multiple cohorts. [2] This genetic predisposition suggests a potential for identifying individuals at elevated risk for developing appendicitis, paving the way for more personalized approaches in prevention or early intervention strategies.
The association of PITX2 with appendicitis has been observed to strengthen with increasing age of onset, and previous research suggests potentially different genetic mechanisms or effect sizes for appendicitis risk between children and adults. [2] Understanding these age-specific genetic influences and the non-coding nature of the identified variants, which imply regulatory functions, could refine risk stratification models. This would allow for targeted monitoring or preventive measures for high-risk individuals within specific demographic groups, thereby improving clinical utility.
Molecular Markers for Disease Severity and Progression
Molecular analyses provide insights into the progression and severity of appendicitis, offering potential diagnostic and prognostic tools. Investigation of gene expression in pediatric appendix tissue samples, categorized by inflammation levels from uninflamed to perforated, revealed significant differential expression for several genes. [2] Specifically, PITX2, UBA7, CD53, and RHOA demonstrated significant trends in expression levels correlating with the degree of inflammation or perforation.
These gene expression profiles suggest their utility as valuable biomarkers in clinical settings. Identifying distinct molecular signatures associated with different stages of appendiceal inflammation could aid in more accurate risk assessment for complications, guide treatment selection, and inform monitoring strategies for patients presenting with suspected appendicitis. [2] Such molecular markers could potentially enhance diagnostic accuracy, reduce negative appendectomy rates, and ultimately improve patient care.
Pathophysiological Insights and Clinical Implications
The identification of PITX2 as a risk gene for appendicitis offers critical pathophysiological insights, given its known role in fetal development, particularly in the morphogenesis of the cecum, where the appendix originates. [2] This connection suggests that subtle developmental variations or regulatory dysfunctions influenced by PITX2 could predispose individuals to appendiceal pathology. Understanding these developmental origins of susceptibility may reveal novel targets for prevention or therapeutic interventions.
The exact pathophysiology of appendicitis remains a subject of ongoing research, with current understanding often considering it a unique disease process distinct from other inflammatory disorders of the gastrointestinal tract. [2] However, genetic findings such as the PITX2 association contribute significantly to unraveling its biological basis and potential predispositions. [2] Further exploration of PITX2's role and the functions of other differentially expressed genes could enhance our understanding of appendiceal inflammation, potentially offering new perspectives on its development and broader clinical implications.
Epidemiological Landscape and Genetic Predisposition
Appendectomy, often performed due to acute appendicitis, is a prevalent medical condition affecting approximately 9% of Americans, making it the most common diagnosis requiring hospitalization for both children and adults. [1] Population studies have consistently demonstrated a significant genetic component underlying susceptibility to appendicitis. Heritability estimates derived from twin and complex segregation studies range between 27% and 56%, indicating that genetic factors play a substantial role in an individual's risk. [13] These findings underscore the importance of genetic research in understanding the etiology of appendicitis and identifying specific genetic variants contributing to its incidence.
Beyond genetic factors, demographic characteristics such as age and sex are consistently considered in epidemiological analyses of appendicitis. Studies have explored age-specific and sex-specific incidence rates, revealing variations in disease patterns across different demographic groups. [23] For instance, research has suggested that genetic mechanisms or the effect sizes of genetic risk factors for appendicitis may differ between children and adults, with some genetic associations showing stronger effects with increasing age of onset. [1] This age-dependent genetic influence highlights the complexity of appendicitis and informs study designs, such as setting minimum age criteria for unaffected control participants to minimize the inclusion of individuals who may be susceptible but have not yet developed the condition. [1]
Global Genetic Insights from Large-Scale Cohorts
Large-scale genome-wide association studies (GWAS) have been instrumental in identifying genetic loci associated with appendectomy. A significant GWAS conducted by Orlova et al. utilized a cohort of 18,773 affected and 114,907 unaffected individuals from 23andMe, identifying a genome-wide significant locus on chromosome 4q25 near the PITX2 gene, with the lead SNP being rs2129979. [1] This discovery was subsequently replicated in an independent cohort, and further strengthened through a meta-analysis that combined data from the 23andMe and COHRA1 cohorts with additional cohorts of Icelandic and Dutch ancestry, encompassing a substantial number of participants. [1] The meta-analysis confirmed the robust association of rs2129979 with appendectomy across these diverse European populations, highlighting a consistent genetic signal.
These extensive cohort investigations provide critical insights into the genetic architecture of appendicitis, particularly the role of the 4q25 locus and PITX2. The findings from these large-scale studies also contribute to understanding temporal dynamics, as previous research had indicated that the association with PITX2 might be stronger in adults compared to children. [1] This age-related difference suggests that the genetic underpinnings of appendicitis may evolve or manifest differently across the lifespan, influencing how genetic risk factors are interpreted, especially when analyzing gene expression in pediatric versus adult appendix samples. [1] The comprehensive nature of these studies, involving thousands of individuals, allows for a powerful assessment of genetic associations at a population level.
Ancestry-Specific Analyses and Methodological Rigor
Population studies on appendectomy emphasize careful consideration of ancestry to ensure the validity and generalizability of genetic findings. The initial GWAS and subsequent replication efforts focused predominantly on individuals of European ancestry, including participants with at least 97% European genetic background, and specifically non-Hispanic European ancestry in the replication cohort. [1] To account for potential population stratification, a critical methodological step involved adjusting for principal components of ancestry in the genetic association analyses, thereby minimizing spurious associations due to population structure. [1] The meta-analysis further extended these comparisons by integrating data from distinct European populations, such as Icelandic and Dutch cohorts, demonstrating the consistency of genetic signals across different European ancestral groups. [1]
Despite the robust methodologies employed, including large sample sizes and comprehensive genetic imputation, population studies on appendectomy inherently face certain limitations. A notable aspect is the reliance on self-reported appendectomy as the phenotype, which, while yielding strong associations, carries the potential for misclassification due to recall bias or the inclusion of incidental appendectomies. [1] However, researchers noted that such misclassification would typically bias findings towards the null hypothesis, rather than causing false positive results, thus lending credibility to the observed associations. [1] Furthermore, while some replication cohorts might be statistically underpowered to independently detect signals, the overall evidence from combined meta-analyses reinforces the strength of the identified genetic loci. [1] The use of pediatric samples for gene expression analyses also presents a limitation, as the age-dependent nature of some genetic associations suggests that findings might differ in adult populations. [1]
Frequently Asked Questions About Appendectomy
These questions address the most important and specific aspects of appendectomy based on current genetic research.
1. My family has appendicitis history. Am I at higher risk?
Yes, there's a strong genetic component to appendicitis risk. Studies show that between 27% and 56% of your susceptibility is inherited. So, if appendicitis runs in your family, you might indeed have a higher genetic predisposition.
2. My sibling never got appendicitis, but I did. Why?
Even with shared genetics, individual risk varies. While genes like PITX2 play a role in susceptibility, the specific combination of genetic variants you inherited, compared to your sibling, can lead to different outcomes. It's not always an all-or-nothing inheritance.
3. Can my lifestyle prevent me from getting appendicitis?
The exact causes of appendicitis aren't fully understood, but genetic factors are a significant contributor. Unlike some other inflammatory conditions, lifestyle factors like diet or exercise haven't been consistently shown to prevent appendicitis. Current research points more towards genetic susceptibility.
4. Does appendicitis just run in certain families?
Yes, it often appears to. Genetic studies suggest that a significant portion of the risk, between 27% and 56%, is inherited. This means that if appendicitis is common in your family, it's likely due to shared genetic predispositions that increase susceptibility.
5. Does my ethnic background change my appendicitis risk?
Potentially, yes. Current genetic findings, like the association near the PITX2 gene (specifically the rs2129979 variant), were primarily identified in people of European ancestry. It's possible that different genetic risk factors or effect sizes exist in other ethnic groups, so your background could influence your specific risk profile.
6. Can I get a DNA test to know my appendicitis risk?
While specific genetic markers like the rs2129979 variant near PITX2 have been identified, current DNA tests aren't routinely used for predicting individual appendicitis risk. The genetic landscape is complex, and more research is needed to develop comprehensive and clinically actionable predictive tests for the general population.
7. Does my risk for appendicitis change as I get older?
Yes, the risk seems to evolve with age. Appendicitis is most common in individuals during their second and third decades of life. Interestingly, the genetic association with the PITX2 region has been observed to be stronger in adults compared to children, suggesting age-related differences in genetic influence.
8. Why do some people seem more prone to appendicitis?
A significant part of that predisposition comes down to genetics. Heritability estimates range from 27% to 56%, meaning some individuals inherit a higher susceptibility. Specific genetic regions, like the one near the PITX2 gene, are associated with an increased chance of developing the condition.
9. If my child gets appendicitis, could it be from my genes?
It's certainly possible. Genetic factors contribute significantly to appendicitis susceptibility, with heritability estimates ranging from 27% to 56%. So, if you or other family members have had appendicitis, your child might have inherited some of that genetic predisposition.
10. Am I just genetically predisposed to needing an appendectomy?
For many people, yes. Genetic factors are recognized as contributing to an individual's susceptibility, with studies showing that inherited factors account for 27% to 56% of the risk. This means your genes can indeed make you more prone to developing appendicitis and needing surgery.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
[1] Orlova E, Yeh A, Shi M, Firek B, Ranganathan S, 23andMe Research Team, Whitcomb DC, Finegold DN, Ferrell RE, Barmada MM, Marazita ML, Hinds DA, Shaffer JR, Morowitz MJ (2018) Genetic association and differential expression of PITX2 with acute appendicitis. Hum Genet 138:37–47.
[2] Orlova, E. "Genetic association and differential expression of PITX2 with acute appendicitis." Hum Genet, vol. 138, no. 1, 2019, pp. 37–47.
[3] Kristjansson RP, Benonisdottir S, Oddsson A, Galesloot TE, Thorleifsson G, Aben KK, Davidsson OB et al (2017) Sequence variant at 4q25 near PITX2 associates with appendicitis. Sci Rep 7(1):3119.
[4] Anderson JE, Stephen W, Bickler DC, Chang, Talamini MA (2012) Examining a common disease with unknown etiology: trends in epidemiology and surgical management of appendicitis in California, 1995–2009. World J Surg 36(12):2787–2794.
[5] Minneci PC, Mahida JB, Lodwick DL, Sulkowski JP, Nacion KM, Cooper JN, Ambeba EJ, Moss RL, Deans KJ (2016) Effectiveness of patient choice in nonoperative vs surgical management of pediatric uncomplicated acute appendicitis. JAMA Surg 151(5):408.
[6] Barrett ML, Hines A, Roxanne MA (2013) “Trends in rates of perforated appendix, 2001–2010.” HCUP statistical brief #159. Agency for Healthcare Research and Quality, Rockville.
[7] Apfel CC, Heidrich FM, Jukar-Rao S, Jalota L, Hornuss C, Whelan RP, Zhang K, Cakmakkaya OS (2012) Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth 109(5):742–753.
[8] Dalal I, Somekh E, Bilker-Reich A, Boaz M, Gorenstein A, Serour F (2005) Serum and peritoneal inflammatory mediators in children with suspected acute appendicitis. Arch Surg 140(2):169.
[9] Adamidis E, Roma-Giannikou K, Kar D (2000) Fiber intake and childhood appendicitis. Int J Food Sci Nutr 51(3):153–157.
[10] Donaldson GP, Lee SM, Mazmanian SK (2015) Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14(1):20–32.
[11] Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA et al (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339–1353.e21.
[12] Jackson HT, Mongodin EF, Davenport KP, Fraser CM, Sandler AD, Steven LZ (2014) Culture-independent evaluation of the appendix and rectum microbiomes in children with and without appendicitis. PloS One 9(4):e95414.
[13] Basta M, Morton NE, Mulvihill JJ, Radovanović Z, Radojicić C, Marinković D (1990) Inheritance of acute appendicitis: familial aggregation and evidence of polygenic transmission. Am J Hum Genet 46(2):377–382.
[14] Sadr Azodi O, Andrén-Sandberg Å, Larsson H (2009) Genetic and environmental influences on the risk of acute appendicitis in twins. Br J Surg 96(11):1336–1340.
[15] Singh, J. P., & Mariadason, J. G. (2013). Role of the faecolith in modern-day appendicitis. Ann R Coll Surg Engl, 95(1), 48–51.
[16] Murphy, C. G., Glickman, J. N., Tomczak, K., Wang, Y. Y., Beggs, A. H., Shannon, M. W., & Horwitz, B. H. (2008). Acute appendicitis is characterized by a uniform and highly selective pattern of inflammatory gene expression. Mucosal Immunol, 1(4), 297–308.
[17] Zeillemaker AM, Hoynck van AA, Papendrecht MH, Hart D, Roos HA, Verbrugh, Leguit P (1996) Peritoneal interleukin-8 in acute appendicitis. J Surg Res 62(2):273–277.
[18] Yoon DY, Chu CJ, Chandler S, Hiyama JE, Thompson, Oscar JH (2002) Human cytokine levels in nonperforated versus perforated appendicitis: molecular serum markers for extent of disease?. Am Surg 68(12):1033–1037.
[19] Bentham, J., Michell, A. C., Lockstone, H., Andrew, D., Schneider, J. E., Brown, N. A., & Bhattacharya, S. (2010). Maternal high-fat diet interacts with embryonic Cited2 genotype to reduce Pitx2c expression and enhance penetrance of left–right patterning defects. Hum Mol Genet, 19(17), 3394–3401.
[20] Shi, T., Xie, Y., Fu, Y., Zhou, Q., Ma, Z., Ma, J., Huang, Z., Zhang, J., & Chen, J. (2017). The signaling axis of microRNA-31/interleukin-25 regulates Th1/Th17-mediated inflammation response in colitis. Mucosal Immunol, 10(4), 983–995.
[21] Arnbjörnsson E (1983) Acute appendicitis and dietary fiber. Arch Surg 118(7):868–870.
[22] Steegenga, W. T., Mischke, M., Lute, C., Boekschoten, M. V., Lendvai, A., Maurien, G. M., Pruis, H. J., Verkade, et al. (2017). Maternal exposure to a western-style diet causes differences in intestinal microbi-. (This title is truncated in the source text, so I include it as provided).
[23] Körner, H., et al. "Incidence of acute nonperforated and perforated appendicitis: age-specific and sex-specific analysis." World J Surg, vol. 21, 1997, pp. 313–317.